County
Laurens County Emergency Medical Services
Laurens County Emergency Medical Services (SC) carries 43 drugs across 134 dose entries in its current published protocol, effective 2025-07-01.
Drugs and doses43
Acetaminophen
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Fever | adult | 1000 mg | IV | not captured | standing | page 92 |
| Fever | peds | 15 mg/kg | PO | not captured | standing | page 94 |
| Mild to moderate pain | adult | 325–1000 mg | PO | not captured | standing | page 85 |
| Mild to moderate pain | peds | 15 mg/kg | PO | not captured | standing | page 85 |
Adenosine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| SVT | adult | 12 mg | IV/IO | not captured | standing | page 66 |
| SVT | peds | 0.1 mg/kg | IV/IO | not captured | standing | page 66 |
Albuterol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 5 mg | NEB | not captured | standing | page 36 |
| Asthma / bronchospasm | peds | 2.5 mg | NEB | not captured | standing | page 36 |
| Hyperkalemia | adult | Continuous | NEB | not captured | standing | page 95 |
| Hyperkalemia | peds | Continuous | NEB | not captured | standing | page 95 |
Amiodarone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Wide-complex tachycardia | adult | 150 mg | IV/IO | not captured | standing | page 67 |
| Wide-complex tachycardia | peds | 5 mg/kg | IV/IO | not captured | standing | page 67 |
| VF / pulseless VT | adult | 300 mg | IV/IO | not captured | standing | page 68 |
| VF / pulseless VT | peds | 5 mg/kg | IV/IO | not captured | standing | page 68 |
Aspirin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 324 mg | PO | not captured | standing | page 63 |
Atropine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Bradycardia | adult | 0.5–1 mg | IV/IO | not captured | standing | page 64 |
| Bradycardia | peds | 0.02 mg/kg | IV/IO | not captured | standing | page 64 |
| Organophosphate poisoning | adult | 1–2 mg | IV/IO | not captured | standing | page 128 |
| Organophosphate poisoning | peds | 0.05–0.1 mg/kg | IV/IO | not captured | standing | page 128 |
Calcium Chloride
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiac arrest | adult | 1 g | IV/IO | not captured | standing | page 172 |
| Hyperkalemia | adult | 1 g | IV/IO | not captured | standing | page 172 |
Calcium Gluconate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Beta-blocker / calcium-channel-blocker overdose | adult | 10–20 mL | IV/IO | not captured | standing | page 158 |
| Beta-blocker / calcium-channel-blocker overdose | peds | 50–100 mg/kg | IV/IO | not captured | standing | page 158 |
| Hyperkalemia | adult | 10–20 mL | IV/IO | not captured | standing | page 158 |
| Hyperkalemia | peds | 50–100 mg/kg | IV/IO | not captured | standing | page 158 |
| Other | adult | 10–20 mL | IV/IO | not captured | standing | page 158 |
| Other | adult | 3 g | IV/IO | not captured | standing | page 96 |
| Other | peds | 50–100 mg/kg | IV/IO | not captured | standing | page 158 |
Ceftriaxone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Sepsis | adult | 2 g | IV/IO | not captured | standing | page 169 |
| Trauma / hemorrhage | adult | 2 g | IV/IO | not captured | standing | page 169 |
| Trauma / hemorrhage | peds | 50 mg/kg | IV/IO | not captured | standing | page 169 |
Dextrose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 25 g | IV/IO | not captured | standing | page 159 |
| Hypoglycemia | peds | 0.5–1 g/kg | IV/IO | not captured | standing | page 159 |
| Other | adult | 25 g | IV/IO | not captured | standing | page 159 |
| Other | peds | 0.5–1 g/kg | IV/IO | not captured | standing | page 159 |
| Seizure | adult | 25 g | IV/IO | not captured | standing | page 159 |
| Seizure | peds | 0.5–1 g/kg | IV/IO | not captured | standing | page 159 |
Diazepam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 1–5 mg | IV/IO/IM | not captured | standing | page 159 |
| Agitation | peds | 0.2 mg/kg | IV/IO/IM | not captured | standing | page 159 |
| Other | peds | 0.2 mg/kg | IV/IO/IM | not captured | standing | page 159 |
| Procedural sedation | peds | 0.2 mg/kg | IV/IO/IM | not captured | standing | page 159 |
| RSI induction | adult | 1–5 mg | IV/IO/IM | not captured | standing | page 159 |
| RSI induction | peds | 0.2 mg/kg | IV/IO/IM | not captured | standing | page 159 |
| Seizure | peds | 0.2 mg/kg | IV/IO/IM | not captured | standing | page 159 |
| Status epilepticus | adult | 1–5 mg | IV/IO/IM | not captured | standing | page 159 |
| Status epilepticus | peds | 0.2 mg/kg | IV/IO/IM | not captured | standing | page 159 |
Diltiazem
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Atrial fibrillation with RVR | adult | 20 mg | IV/IO | not captured | standing | page 159 |
| SVT | adult | 20 mg | IV/IO | not captured | standing | page 159 |
Diphenhydramine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 50 mg | IV/IM | not captured | standing | page 160 |
| Allergic reaction | adult | 50 mg | IV/IM | not captured | standing | page 160 |
| Allergic reaction | peds | 1 mg/kg | IV/IM | not captured | standing | page 160 |
| Allergic reaction | peds | 1 mg/kg | IV/IM | not captured | standing | page 160 |
| Anaphylaxis | adult | 50 mg | IV/IM | not captured | standing | page 160 |
| Anaphylaxis | peds | 1 mg/kg | IV/IM | not captured | standing | page 160 |
| Dystonic reaction | adult | 50 mg | IV/IM | not captured | standing | page 160 |
| Dystonic reaction | peds | 1 mg/kg | IV/IM | not captured | standing | page 160 |
Dopamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiogenic shock | adult | 5–20 mcg/kg | IV/IO | not captured | standing | page 160 |
| Cardiogenic shock | peds | 2–5 mcg/kg | IV/IO | not captured | standing | page 160 |
| Hypotension / shock | adult | 5–20 mcg/kg | IV/IO | not captured | standing | page 160 |
| Hypotension / shock | peds | 2–5 mcg/kg | IV/IO | not captured | standing | page 160 |
Epinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 0.3 mg | IM | not captured | standing | page 76 |
| Allergic reaction | peds | 0.15 mg | IM | not captured | standing | page 76 |
| Anaphylaxis | adult | 0.5 mg | IM | not captured | standing | page 75 |
| Anaphylaxis | adult | 0.5 mg | IV/IO | not captured | standing | page 75 |
| Anaphylaxis | peds | 0.01 mg/kg | IM | not captured | standing | page 75 |
| Anaphylaxis | peds | 0.01 mg/kg | IV/IO | not captured | standing | page 75 |
| Bradycardia | adult | 2–10 mcg | IV/IO | not captured | standing | page 64 |
| Bradycardia | peds | 0.01 mg/kg | IV/IO | not captured | standing | page 64 |
| Cardiac arrest | adult | 1 mg | IV/IO | not captured | standing | page 68 |
| Cardiac arrest | peds | 0.01 mg/kg | IV/IO | not captured | standing | page 68 |
| Hypotension / shock | adult | 1–2 mL | IV/IO | not captured | standing | page 82 |
Etomidate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| RSI induction | adult | 15–30 mg | IV/IO | not captured | standing | page 60 |
Fentanyl
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 25–50 mcg | IV/IO/IM/IN | not captured | standing | page 63 |
| Mild to moderate pain | peds | 1 mcg/kg | IV/IO/IM/IN | not captured | standing | page 63 |
Furosemide
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| CHF / pulmonary edema | adult | 40–80 mg | IV/IO/IM | not captured | standing | page 161 |
| CHF / pulmonary edema | peds | 2 mg/kg | IV/IO/IM | not captured | standing | page 161 |
Glucagon
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Beta-blocker / calcium-channel-blocker overdose | adult | 2 mg | IV/IO/IM | not captured | standing | page 161 |
| Bradycardia | adult | 2 mg | IV/IO | not captured | standing | page 64 |
| Hypoglycemia | adult | 1 mg | IM/IN/SQ | not captured | standing | page 74 |
| Hypoglycemia | peds | 0.1 mg/kg | IM/IN/SQ | not captured | standing | page 74 |
Heparin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 5000 unit | IV | not captured | standing | page 63 |
Ketamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 2–4 mg/kg | IM | not captured | standing | page 77 |
Labetalol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 10 mg | IV/IO | not captured | standing | page 79 |
Levalbuterol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 1.25 mg | NEB | not captured | standing | page 170 |
Levetiracetam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Status epilepticus | adult | 2 g | IV/IO | not captured | standing | page 91 |
| Status epilepticus | peds | 20 mg/kg | IV/IO | not captured | standing | page 91 |
Lidocaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiac arrest | adult | 1–1.5 mg/kg | IV/IO | not captured | standing | page 163 |
| Mild to moderate pain | adult | 40 mg | IO | not captured | standing | page 48 |
| Wide-complex tachycardia | adult | 0.5–0.75 mg/kg | IV/IO | not captured | standing | page 163 |
Lorazepam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 1 mg | IV/IO/IM | not captured | standing | page 90 |
| Procedural sedation | adult | 1 mg | IV/IO/IM | not captured | standing | page 90 |
| Seizure | adult | 1–2 mg | IV/IO/IM | not captured | standing | page 91 |
| Seizure | peds | 0.1 mg/kg | IV/IO/IM | not captured | standing | page 91 |
Magnesium Sulfate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 2 g | IV/IO | not captured | standing | page 88 |
| Asthma / bronchospasm | peds | 40 mg/kg | IV/IO | not captured | standing | page 88 |
| Eclampsia / pre-eclampsia | adult | 4 g | IV/IO | not captured | standing | page 78 |
Methylprednisolone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 125 mg | IV/IO | not captured | standing | page 75 |
| Anaphylaxis | peds | 2 mg/kg | IV/IO | not captured | standing | page 75 |
| Asthma / bronchospasm | adult | 125 mg | IV/IO | not captured | standing | page 88 |
| Asthma / bronchospasm | peds | 2 mg/kg | IV/IO | not captured | standing | page 88 |
Midazolam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 5 mg | IM | not captured | standing | page 164 |
| Other | adult | 1–2.5 mg | IV | not captured | standing | page 90 |
| Post-intubation sedation | adult | 2.5 mg | IV/IO | not captured | standing | page 61 |
| Seizure | adult | 5–10 mg | IM/IN | not captured | standing | page 77 |
| Seizure | peds | 0.1 mg/kg | IM | not captured | standing | page 112 |
| Seizure | peds | 0.1–0.25 mg/kg | IV/IO | not captured | standing | page 112 |
Morphine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 0.1 mg/kg | IV/IO/IM | not captured | standing | page 85 |
| Mild to moderate pain | adult | 2 mg | IV | not captured | standing | page 63 |
| Mild to moderate pain | peds | 0.1 mg/kg | IV/IO/IM | not captured | standing | page 85 |
Naloxone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Opioid overdose | adult | 2 mg | IV/IM | not captured | standing | page 86 |
| Opioid overdose | peds | 0.1 mg/kg | IV/IM | not captured | standing | page 86 |
Nitroglycerin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 0.4 mg | SL | not captured | standing | page 63 |
Norepinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypotension / shock | adult | 2–30 mcg | IV/IO | not captured | standing | page 166 |
Ondansetron
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 4 mg | IV/IM | not captured | standing | page 63 |
| Nausea / vomiting | peds | 2 mg | IV/IM | not captured | standing | page 63 |
Piperacillin-Tazobactam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Sepsis | adult | 3.375 g | IV/IO | not captured | standing | page 92 |
Pralidoxime
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nerve agent exposure | adult | 1000–2000 mg | IV/IM | not captured | standing | page 166 |
| Nerve agent exposure | peds | 20–50 mg/kg | IV/IM | not captured | standing | page 166 |
Racemic Epinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Croup | peds | 0.5 mL | NEB | not captured | standing | page 166 |
Rocuronium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| RSI induction | adult | 100 mg | IV/IO | not captured | standing | page 167 |
Sodium Bicarbonate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiac arrest | adult | 1 mEq/kg | IV/IO | not captured | standing | page 167 |
| Cardiac arrest | peds | 1 mEq/kg | IV/IO | not captured | standing | page 167 |
| Hyperkalemia | adult | 1 mEq/kg | IV/IO | not captured | standing | page 167 |
| Hyperkalemia | peds | 1 mEq/kg | IV/IO | not captured | standing | page 167 |
| Other | adult | 1 mEq/kg | IV/IO | not captured | standing | page 167 |
| Other | peds | 1 mEq/kg | IV/IO | not captured | standing | page 167 |
| Tricyclic overdose | adult | 1 mEq/kg | IV/IO | not captured | standing | page 167 |
| Tricyclic overdose | peds | 1 mEq/kg | IV/IO | not captured | standing | page 167 |
Succinylcholine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| RSI induction | adult | 150 mg | IV/IO | not captured | standing | page 168 |
Terbutaline
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Respiratory distress | adult | 0.25 mg | SQ | not captured | standing | page 171 |
| Respiratory distress | peds | 0.01 mg/kg | SQ | not captured | standing | page 171 |
Tetracaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 2 drop | not captured | not captured | standing | page 168 |
Vecuronium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 10 mg | IV/IO | not captured | standing | page 170 |
| RSI induction | adult | 10 mg | IV/IO | not captured | standing | page 170 |